Orally available stilbene derivatives as potent HDAC inhibitors with antiproliferative activities and antitumor effects in human tumor xenografts.
- Additional Document Info
- View All
Herein we report the synthesis and activity of a novel class of HDAC inhibitors based on 2, 3-diphenyl acrylic acid derivatives. The compounds in this series have shown to be potent HDAC inhibitors possessing significant antiproliferative activity. Further compounds in this series were subjected to metabolic stability in human liver microsomes (HLM), mouse liver microsomes (MLM), and exhibits promising stability in both. These efforts culminated with the identification of a developmental candidate (5a), which displayed desirable PK/PD relationships, significant efficacy in the xenograft models and attractive ADME profiles.
author list (cited authors)
Kachhadia, V., Rajagopal, S., Ponpandian, T., Vignesh, R., Anandhan, K., Prabhu, D., ... Gopalan, B.
complete list of authors
Kachhadia, Virendra||Rajagopal, Sridharan||Ponpandian, Thanasekaran||Vignesh, Radhakrishnan||Anandhan, Karnambaram||Prabhu, Daivasigamani||Rajendran, Praveen||Nidhyanandan, Saranya||Roy, Anshu Mittal||Ahamed, Fakrudeen Ali||Surendran, Narayanan||Rajagopal, Sriram||Narayanan, Shridhar||Gopalan, Balasubramanian